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Secretory and membrane proteins from mammalian
cells undergo post-translational modifications,
including N-linked glycosylation, which can result in
a large number of possible glycoforms. This sample
heterogeneity can be problematic for structural
studies, particularly X-ray crystallography. Thus,
crystal structures of heavily glycosylated proteins
such as the HIV-1 Env viral spike protein have been
determined by removing the majority of glycans.
This step is most frequently carried out using Endo-
glycosidase H (EndoH) and requires that all ex-
pressed glycans be in the high-mannose form, which
is often not the native glycoform. With significantly
improved technologies in single-particle cryoelec-
tron microscopy, we demonstrate that it is now
possible to refine and build natively glycosylated
HIV-1 Env structures in solution to 4.36 A˚ resolution.
At this resolution we can now analyze the complete
epitope of a broadly neutralizing antibody (bnAb),
PGT128, in the context of the trimer expressed with
native glycans.
INTRODUCTION
Many proteins, including those of viral and eukaryotic origin,
often have post-translational modifications (PTMs) that make
them difficult to study at high resolution using X-ray crystallog-
raphy, due to intrinsic compositional or conformational hetero-
geneity. N- and O-linked glycosylation occurs in the majority of
proteins that pass through the secretory pathway, and serves
roles in both protein folding and function. Glycosylated proteins
have been especially difficult to study structurally due to the na-
ture of the modification, which can be extremely diverse even at
a single residue andmay contain a large range of conformational
motion. In X-ray crystallography, these challenges are overcome
by either removing glycosylation sites by mutagenesis, or pro-
ducing the proteins in expression systems that limit the glycosyl-Structure 23, 1943–ation pathway. For example, GnTI-deficient HEK293S cells
produce proteins with all high-mannose glycans that can be de-
glycosylated with Endoglycosidase H (EndoH), leaving only the
N-linked core N-acetylglucosamine (N-GlcNAc) (Depetris et al.,
2012; Julien et al., 2013a; Lee et al., 2008; Pancera et al.,
2014). However, the major caveat of this approach is that the
protein cannot be crystallized in its native form, which is espe-
cially disadvantageous when attempting to solve structures of
glycoprotein complexes in which the binding partner recognizes
complex glycans.
HIV-1 envelope glycoprotein (Env), the fusion machine on the
surface of HIV-1, is metastable and one of the most highly glyco-
sylated protein complexes known, and has been subject to all of
the above challenges. A soluble Env trimer construct termed
BG505 SOSIP.664, derived from the sequence of clade A virus
BG505, with an introduced gp120-gp41 heterodimer linking di-
sulfide bond (SOS) (Binley et al., 2000), and pre-fusion conforma-
tion stabilizing I559P mutation (IP) (Sanders et al., 2002) was
used to overcome the lack of trimer stability for multiple struc-
tural studies (Garces et al., 2014; Huang et al., 2014; Julien
et al., 2013a, 2013b, 2013c; Khayat et al., 2013; Kong et al.,
2013; Lyumkis et al., 2013; Pancera et al., 2014). Although the
ability to generate a stable native-like soluble Env trimer was a
major breakthrough, structural characterization of Env glycans
remains an arduous task. Despite the fact that the outer domain
of Env is heavily packed with glycans they are highly flexible, and
often not resolved unless directly bound, and thus stabilized, by
an antibody that recognizes the particular glycan. Indeed, struc-
tures of themajority of glycans on Env larger than the core trisac-
charide have been determined in this manner (Garces et al.,
2014; Julien et al., 2013a, 2013c; Kong et al., 2013; McLellan
et al., 2011; Pejchal et al., 2011), as the glycans not interacting
with antibodies are disordered, or are accessible to EndoH in
the deglycosylation step. As such, with current methods anti-
bodies that recognize complex glycans often cannot be co-
crystallized as an antibody-antigen complex, and thus the
untrimmed, large complex glycans predicted to be on trimeric
Env have not been observed at high resolution.
The advent of high-resolution single-particle cryoelectron mi-
croscopy (cryo-EM) overcomes the limitations of flexibility and
PTMs, particularly glycosylation, because crystallization is not
required. In fact, it has been shown previously that with cryo-EM1951, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1943
the natively glycosylated BG505 SOSIP.664 trimer with PGV04
fragment antigen binding (Fab) canbe determined to 5.8 A˚ resolu-
tion (Lyumkis et al., 2013), allowing apartial pseudo-atomicmodel
of the peptide to be built. In this study, despite density corre-
sponding to glycans being resolved in the EM map, the glycans
were not built into the model (Lyumkis et al., 2013). Here we pre-
sent a 4.36-A˚ cryo-EM reconstruction of natively glycosylated
BG505 SOSIP.664 in complex with a potent broadly neutralizing
antibody (bnAb) PGT128, which binds the high-mannose patch
of gp120 surrounding the N332 glycan (Pejchal et al., 2011; Sok
et al., 2014; Walker et al., 2011). The resolution of this newmodel
is similar to those of the two published X-ray structures of degly-
cosylated Env trimers in complex with different antibodies, at
4.7 and 3.5 A˚ resolution (Julien et al., 2013a; Pancera et al.,
2014). Combining our high-resolution EM map and published
X-ray data (Pancera et al., 2014; Pejchal et al., 2011) enabled
us to build an atomic model of the HIV Env trimer, including
many ordered glycans. This breakthrough enables resolution
of the complete epitope of the bnAb PGT128 and provides a
path forward foranalyzingotherbnAbswithcomplex,glycan-con-
taining epitopes.
RESULTS
Cryo-EM of BG505 SOSIP.664 Env Trimer in Complex
with PGT128 Fab
Two datasets of the BG505 SOSIP.664-PGT128 Fab complex
were collected, and initially independently processed (Figure S1).
The reconstruction of the first dataset was resolved to 4.67 A˚
while the second dataset was resolved to 5.01 A˚ at a Fourier shell
correlation (FSC) cutoff of 0.143, both using the same gold-stan-
dard refinement procedure (Figure S1E), with images recorded
at similar dose and defocus range (Table S1). Combining the
two datasets improved the resolution to 4.47 A˚ (Figure S1E
and Table S1). Throughout the 3D classification procedure and
in the final refined models, it was apparent that the constant re-
gion of the Fab was highly flexible, and the greatest degree of
variability among the 3D classes was in this region (Figure S1B).
To improve resolution further, we subjected the model from the
final refinement iteration to additional rounds of local refinement
after imposing a mask shaped like the molecule but excluding
the Fab constant region from particle alignment (Figure S1D).
This resulted in a slight improvement in the resolution to 4.36 A˚
(Figures 1A and S1E; Table S1). Local resolution analysis of
this reconstruction shows that the resolution of the molecule is
mainly isotropic (Figure 1B). As expected, the Fab constant re-
gion exhibited the lowest resolution, ranging between 5 and
10 A˚ (Figure 1B).
Density Map Analysis and Model Building
The a-helical regions in both gp120 and gp41were well resolved,
including the helical pitch, with many side chains visible, particu-
larly on internal helices (Figures 2AandS2A). Individual strands of
b sheets were also well resolved (Figures 2B and S2B). Docked
coordinates of the 3.5-A˚ resolution X-ray structure of the SOSIP
trimer (PDB: 4TVP) (Pancera et al., 2014) and the Fab variable re-
gion of the PGT128 Fab (PDB: 3TYG) (Pejchal et al., 2011) were
used for atomic model building and refinement into the cryo-
EM map, as the X-ray structures contained protein regions that1944 Structure 23, 1943–1951, October 6, 2015 ª2015 Elsevier Ltd Awere of the same construct as those used in the cryo-EM com-
plex, and each piece showed a good overall fit to the density.
The majority of the structure did not have to be modified, with
the exception of a change in V1, which is in a slightly different
conformation relative to the conformation in the PGT122 bound
state. The few inconsistencies were remodeled in Coot (Emsley
and Cowtan, 2004) and refined in RosettaRelax (DiMaio et al.,
2009, 2015) (Figure S2C).
A superimposition of the refined trimer structure to the initial
model results in a Ca root-mean-square deviation of 1.44 A˚ (Fig-
ure 1C), demonstrating that the majority of the structure is highly
similar, in accordance with the low-resolution EM observation
that PGT128 does not cause a global conformational change in
the trimer upon binding (Pejchal et al., 2011). Outside of the
PGT128 epitope, two regions were structurally distinct from
the crystal structure of the BG505 SOSIP trimer (PDB: 4TVP),
the a0 helix of gp120 (residues 59–63) and the C terminus of
gp41. In the 4TVP X-ray structure (Pancera et al., 2014), the
segment corresponding to residues 59–64 is modeled as a short
a helix, followed by a loop region in residues 64–74. This second-
ary structure configuration is reversed in the 4NCO X-ray struc-
ture (Julien et al., 2013a). In the cryo-EM reconstruction, the
density in both regions appears too disordered to be helical,
and neither of the two structures fit the density corresponding
to residues 59–67 well (Figure 3A). Helices are the first distinctive
secondary structural elements seen in cryo-EM maps once the
resolution reaches <10 A˚. Examination of a4, a helix of six resi-
dues (Figure 3B), suggests that this lack of helical definition is
not due to limitations in resolving a short helix by cryo-EM.
Another indication of disorder in this region is the fact that the
side-chain density of Y61 is not visible, despite the majority of
aromatic residue side chains being resolved in the EM map.
Because we did not observe clear density in the cryo-EM map
between residues A58 and W68, we concluded that this region
is natively disordered and removed this region from our model.
This region may, however, become ordered upon binding to
the receptor CD4, as suggested by the CD4 bound gp120mono-
mer structure (Pancera et al., 2010).
The second structural difference between the cryo-EM and
X-ray models was localized to the C-terminal region of heptad
repeat (HR) 2 of gp41. There is a small downward shift of
3 A˚ in HR2 helix of the cryo-EM model compared with the
35O22 bound structure (Figure 3C), along with reduced helical
integrity. Three possible explanations can be given for this
observation. This region may be flexible as suggested by
hydrogen-deuterium exchange mass spectrometry, showing
rapid deuterium exchange in residues 648–664 of HR2 (Guttman
et al., 2014). Secondly, 35O22, the antibody bound in the crystal
structure, is a gp120-gp41 interface-binding antibody, and
makes contact with the region surrounding N625 of gp41
(Huang et al., 2014), which may cause a slight conformational
shift. Lastly, and most likely, there are crystal-packing interac-
tions between the constant domain of PGT122 Fab and the
C terminus of HR2 in 4TVP. Small differences in this region
were also observed between the 5.8-A˚ EM structure (Lyumkis
et al., 2013), and the 4.7-A˚ X-ray structure (Julien et al.,
2013a). Although the latter two structures lack a full atomic
model for gp41, the models provide additional support that
the HR2 helix is flexible.ll rights reserved
Figure 1. Cryo-EMReconstruction of BG505
SOSIP.664 in Complex with PGT128 Fab
(A) Top (left) and side (right) views of the cryo-EM
reconstruction is segmented into gp120, gp41 in
the trimer, and variable and constant regions in
the Fab.
(B) Local resolution analysis of the 4.36-A˚ resolu-
tion reconstruction. Local resolution in angstroms
is indicated by colors shown in the key at the
bottom. The reconstruction shown at a higher
threshold level (right) shows that the resolution is
largely isotropic, especially at the core of the trimer.
(C) The refined PGT128 bound trimermodel. gp120
and gp41 are shown in pink and yellow, respec-
tively, and glycans are shown as green sticks. Only
the Fab variable region was built. The heavy chain
(HC) is shown in blue and the light chain (LC) in
lavender.
(D) Superposition of the PGT128 bound trimer (pink
and yellow) with the PGT121 and 35O22 bound
trimer solved by X-ray crystallography (gray) (Pan-
cera et al., 2014).The gp120 regions that were unresolved in published X-ray
structures of BG505 SOSIP.664 were similarly not resolved
here. While density was visible in the V2 loop region, lack of defi-
nition in side-chain densities made the Ca trace ambiguous (Fig-
ure 3D). The density corresponding to the V4 loop is almost
entirely missing, as it is in the majority of gp120 structures (Fig-
ure 3E). These regions are consistently disordered in multiple
X-ray and EM structures (Do Kwon et al., 2015; Julien et al.,
2013a; Lyumkis et al., 2013; Pancera et al., 2010), and indicate
that these regions are intrinsically disordered in the Env trimer.
The core of gp41 was one of the best-resolved regions of the
trimer, and exhibited the highest local resolution in the overall
structure (Figure 1B). The density corresponding to the fusionStructure 23, 1943–1951, October 6, 2015 ªpeptide proximal region (FPPR) was
resolved as a continuous density (Fig-
ure 3F), but not ordered enough to build
an atomic model. A few more residues
(548–550 and 566–568) than what is
visible in the 3.5-A˚ X-ray model could be
built confidently from the visible side-
chain density. From this, new interactions
potentially stabilizing the trimeric HR1
coiled-coil were resolved. Specifically,
L568 from the three protomers have hy-
drophobic interactions at the three-fold
axis (Figure 2C), and there is also a poten-
tial hydrogen bonding interaction be-
tween K567 and the backbone carbonyl
of T569 (Figure 2D).
Building andRefinement of Glycans
In X-ray crystallography, mercury label-
ing is often used as a means to confirm
the Ca backbone trace of low-resolution
structures. While N-linked glycans are
flexible and often difficult to resolve fully,
their occurrence is easy to predict (glyco-sylated at NXT/S), and the core N-GlcNAc is almost always
visible as a small protrusion of density in EM and X-ray maps,
even if the resolution is not high enough to resolve protein side
chains or individual glycan residues. In this regard, N-GlcNAc
densities can be utilized as a marker for confirming side-chain
registration in model building, allowing the model to be validated
by glycan densities at potential N-glycosylation (PNG) sites, as
done for the previously published BG505 SOSIP.664 structure
determined by cryo-EM (Lyumkis et al., 2013). Indeed, in the
current EM map, density corresponding to at least the first
N-GlcNAc is visible at all PNG sites except for glycans in disor-
dered loop regions, and N137 and N625 (Figures S3A and S3B).
The N262 glycan was the only glycan not directly interacting with2015 Elsevier Ltd All rights reserved 1945
Figure 2. Analysis of High-Resolution Features andModel Validation
(A) Densities of some of the prominent a helices in the Env trimer.
(B) Densities of some of the prominent b sheets in the Env trimer.
(C) Stereo view of the N-terminal end of the a7 helix of gp41 following the
unresolved fusion peptide proximal region (FPPR). L568 just prior to the start of
the a7 helix of heptad repeat (HR) 1 forms a hydrophobic interaction at the start
of the trimeric coiled-coil at the center of the trimer, and K567 makes in-
teractions with the adjacent HR1 helix. The two residues are shown as yellow
sticks.
(D) A stereo image of a different view of the K567 inter-HR1 interaction.
The K567 side-chain nitrogen could potentially interact with the backbone
1946 Structure 23, 1943–1951, October 6, 2015 ª2015 Elsevier Ltd Athe Fab that had multiple visible branches due to its extensive
contacts with gp120 (Figure 4A). A recent X-ray structure of a
fully glycosylated gp120 core shows a large Man7 glycan at
this position with a fully extended D1 arm (Kong et al., 2015).
We also see large amounts of density for the D1 arm, although
the signal was not strong enough to build the entire D1 branch.
This density extends toward the base of N301, and it appears
that the last D1 arm glycan residue could interact with the
core N-GlcNAc and the D2 branch of N301 (Figure 4B). It has
been previously noted that while glycosylation at N301 is not
an absolute requirement for viral infectivity or Env expression
and folding, the deletion of this glycan renders the trimer more
susceptible to neutralization by V3 loop binding antibodies (Bin-
ley et al., 2010). A similar but less pronounced effect was seen
when all glycans were produced in high-mannose form (Binley
et al., 2010). Because the N301 glycan is predicted to be com-
plex (Cutalo et al., 2004; Leonard et al., 1990; Zhu et al.,
2000), the authors concluded that the modification of the N301
glycan was linked to increased exposure of the V3 loop (Binley
et al., 2010). In this regard, N301 deletion-induced V3 exposure
may be due to the loss in glycan-glycan interaction between
N262 and N301, which helps restrain the V3 loop in the closed
configuration. While we have built the N301 glycan as high-
mannose due to the fact that we are using a published glycan
model for N301, the D2 arm mannose residue is also likely to
be a GlcNAc in complex glycans (Stanley, 2009). Thus it is
possible that the N262-N301 glycan interactions are stronger
when N301 is complex and has a GlcNAc at this position.
Although most glycans were flexible and not visible beyond
the first two GlcNAc residues, glycans interacting with
PGT128 were well resolved, including the multiple branches
of the glycans at N332 and N301. Rigid body docking of the
glycan coordinates obtained from the PGT128 bound engi-
neered mini-gp120 outer domain (gp120 eOD) structure (PDB:
3TYG) localizes the glycans into the cryo-EM density (Figures
4C and 4D), especially the Man8 N332 glycan (Figure 4C),
which fits well into the EM map. We initially docked the N301
Man5 glycan into the EM density, which fit well overall, although
the D3 arm torsions needed to be modified (Figures 4D and
S3C). This D3 arm density is slightly shifted relative to the
X-ray coordinates, and the hydrogen bonding interaction that
was proposed between the mannose O6 and the backbone
carbonyl of P74 in framework region heavy (FWRH) 3 of
PGT128 (Pejchal et al., 2011) is lost (Figure 4E). Analysis of
this linkage indicates that in the original structure the torsion
angle between this glycan and the previous mannose is highly
unlikely, suggesting that perhaps the interaction seen is an
artifact of the crystal structure (Figure S3C). Another possibility
is that N301 in the native expression system is a complex
glycan as discussed above; thus, unlike the X-ray structure
the residues beyond the core pentasaccharide may not be
mannoses, and the branches adopt a slightly different struc-
tural configuration.carbonyl oxygen of T569 (residues shown as yellow sticks and interaction
shown by the dashed line). We can be confident in the relative conformation
due to the clear side-chain density of W571 nearby anchoring the peptide
registration (orange).
ll rights reserved
Figure 3. Regions of the Map with Missing
Density and the FPPR Region
(A) Stereo view of the a0 region (yellow) of pub-
lished trimer structures 4TVP (top), 4NCO (bot-
tom), and our model (blue mesh). The density
of this region in our map fits neither 4NCO nor
4TVP well.
(B) The a4 helix of gp120 (residues T386–N392,
yellow) is well resolved despite it being a small
helix. The N-GlcNAc at N392 is shown in green.
(C) A close-up of the C-terminal region of HR2.
There is a slight downward shift of 3.3 A˚
(measured between Q653 Ca) in the HR2 region of
the PGT128 bound trimer (yellow) in comparison
with the X-ray structure (gray).
(D) The density for the entire V2 loop is visible,
although the lack of confidence in side-chain
densities makes it difficult to build. The dotted line
indicates the loop path of the ten missing residues
(E185a–S187).
(E) The density for the V4 loop is unresolved. The
end and start of the V4 loop in the atomic model is
shown in red, and the predicted path of missing
regions (residues T399–S410) is shown by the
dotted line.
(F) Three gp41 protomer densities are shown as
shades of orange. As in (D), the entire FPPR den-
sity was visible but could not be built unambigu-
ously. Residues Q551–L565 are missing from this
atomic model.Defining the Full PGT128 Epitope
Many HIV-1 bnAbs have previously been solved in complex with
either gp120 or peptide fragments that comprise a part of its
epitope, due to difficulties in crystallizing the entire trimer.
PGT128 binds the gp120 eOD with an 8-fold decrease in affin-
ity relative to the gp120 core with the full V3 (Pejchal et al., 2011),
likely due to lost interactions in the minimized epitope. Indeed, it
has been shown that the extent of HIV-1 binding bnAb epitopes
is often underestimated, as demonstrated by another N301 and
N332 glycan-dependent antibody, PGT122 (Julien et al., 2013c),
whichwas confirmed to have amore expansive epitope involving
V1/V2 glycans (Julien et al., 2013a). Other studies showed similar
results for different antibodies that target the N332 site (Garces
et al., 2014; Sok et al., 2014), and suggested that breadth of
neutralization is derived from the ability of the bnAb to interact
with other nearby glycans in a promiscuous manner when
preferred glycans are not present (Sok et al., 2014). PGT128
and its clonal relatives were shown to have absolute depen-Structure 23, 1943–1951, October 6, 2015 ªdence on the N301 glycan, but partial
dependence on either N295 or N332.
Both N295 and N332 must be knocked
out simultaneously to eliminate the ability
of the antibody to neutralize the virus (Sok
et al., 2014). A model demonstrating how
the N295 glycan would interact in place of
the N332 glycan was previously calcu-
lated using computational methods (Sok
et al., 2014). A comparison of this struc-
ture with our EM-based model indicates
that N295 glycan would have to move60 to interact with the PGT128 Fab in place of N332
(Figure 5A).
It was also shown that glycans at the trimer apex near the
PGT128 binding site have minor effects on PGT128 binding.
When the N137 glycan was knocked out in a BG505 virus lacking
either the N332 or N334 glycan (the latter often being a compen-
satory glycosylation site when N332 is missing), virus neutraliza-
tion by PGT128was increased, while removal of the N156 glycan
resulted in a slight reduction in neutralization potency (Sok et al.,
2014). Because the gp120 eOD in the X-ray structure is missing
most of the V1/V2 region including N137 and N156, which is pre-
sent in our trimer construct, we are now able to examine potential
interactions in this region more completely.
In the cryo-EMmap there is very little density for N137 beyond
the Asn side chain, suggesting that there is no specific interac-
tion between N137 and the PGT128 Fab (Figures 5B and S3A).
Nevertheless, in this V1-loop conformation the N137 residue
projects toward the outer face of PGT128 Fab light chain (LC)2015 Elsevier Ltd All rights reserved 1947
Figure 4. Glycan Interactions Resolved in
the Cryo-EM Structure
(A) Clear density for a Man5 glycan at N262 can be
seen in the EM map.
(B)While the last glycan in the D1 arm has not been
built, we see a small amount of density in this re-
gion (orange) connecting the N262 D1 arm glycan
to the base and D2 arm of the N301 glycan.
(C) The N332 glycan from 3TYG structure fits
tightly into the EMdensity. In blue and lavender are
PGT128 Fab HC and LC, respectively.
(D) The N301 glycan and its density.
(E) The D3 arm of N301 does not interact with P74
(yellow) in PGT128 (HC shown in blue) as was
suggested by the X-ray structure.(Figure 5B). The proximity of N137 to the Fab LC suggests that a
glycan in this position would sterically hinder PGT128 binding,
corroborating the previous knockout study (Sok et al., 2014).
By contrast, density was visible for several sugar moieties of
the N156 glycan at low map contour levels. Examination of this
density suggests a possible interaction between S56 in the LC
complementarity-determining region 2 (CDRL2) of PGT128,
and the D1 arm mannose of the N156 glycan (Figure 5C).
Although density beyond the core trisaccharide was poorly
defined, there are densities branching from theN156 glycan den-
sity that could indicate potential interactions between D27, R94,
and D101 of the Fab heavy chain (HC) (Figure 5C).
In addition to new glycan contacts, we also observed pro-
tein-protein contacts not contained in the gp120 eOD bound
structure (Pejchal et al., 2011). The GDIR motif is a highly
conserved region in the gp120 V3 loop (residues G324–
R327), and it has been predicted that this region is one of the
most important peptide segments for binding of antibodies in
the PGT128-like families (Garces et al., 2014). A comparison
between the gp120 eOD-PGT128 Fab complex and gp120
monomer-PGT124 (another N332-dependent antibody) com-
plex structures demonstrated that PGT124 interacts with the
GDIR motif in a mostly side-chain-dependent manner, while
PGT128 interacts with the backbone of the GDIR segment.
Interestingly, the cryo-EM density reveals a potential side-chain
interaction between D100d of PGT128 HC complementarity-
determining region 3 (CDRH3) and R327 of gp120 (Figure 5D).
Previously published data showed only a small change in both
neutralization IC50 and ELISA EC50 resulting from a D100dA
mutation (Pejchal et al., 2011), indicating that this interaction
may occur but does not play a large role in epitope recognition.
Another possible interaction was detected in b22 of gp120,
which is engineered as a loop in the gp120 eOD, in which1948 Structure 23, 1943–1951, October 6, 2015 ª2015 Elsevier Ltd All rights reservedY52e in CDRH2 packs against Cb-Cd
of R444 (Figure 5E). Unlike the D100dA
mutation, the Y52eA mutation resulted
in a 21.1- and 12.9-fold increase in
neutralization IC50 (for JR-FL and BaL
viral isolates, respectively) relative to
the wild-type antibody (Pejchal et al.,
2011). These additional interactions
stress the importance of analyzing anti-
body-antigen contacts in the context ofthe full epitope, and the ability to resolve such interactions
using cryo-EM.
DISCUSSION
Here, we show that a 4.36-A˚ resolution cryo-EMmap, combined
with refinement in Rosetta, enables model building of protein
complexes with near atomic resolution details (DiMaio et al.,
2015). PTMs, particularly glycans, can serve as markers that
help guide building and confirm registration of the amino acid
sequence. The core N-GlcNAcs are almost always visible in
the density map, while the higher branching is often too flexible
to be resolved unless constrained in some way. While similar
to X-ray crystallography in this regard, the ability to express gly-
coproteins with native glycans, and not remove them prior to
structural analysis, is advantageous. Thus, with current cryo-
EM and detector technology, there will be an increasing number
of biological complexes of interest that require hybrid modeling
and refinement, especially for glycans.
We have now shown that cryo-EM is capable of generating
rapid structural information for iterative, structure-based vaccine
design (Correia et al., 2014; Jardine et al., 2013; McGuire et al.,
2013; McLellan et al., 2013), as is being pursued for HIV-1. In
X-ray crystallography, crystallization is highly dependent on sta-
ble protein-protein crystal contacts, and in fact there are only a
few known combinations of trimer-Fab complexes that result in
sufficiently well-ordered crystals that diffract to a reasonable
resolution. Cryo-EM circumvents this problem, and glycan and
epitope binding analysis can be routinely achieved for any
trimer-Fab complex. Even more promising, there is still room
for improvement in resolution using newer refinement tech-
niques, such as dose fractionation (Bartesaghi et al., 2014) and
particle polishing (Scheres, 2014), which will better correct for
Figure 5. The PGT128 Epitope in the Context of the Full Trimer
(A) TheN295 glycan (green), which can act as a compensatory glycanwhen the
N332 glycan is missing, must move 60 (orange) to compensate for the loss
of N332.
(B) Even though the glycan density cannot be seen, the position of N137
(yellow) indicates that a glycan projecting from this site (orange shading) could
sterically affect PGT128 binding. The lower image is an orthogonal view of the
upper image, to show how the glycan may project out toward the Fab.
(C) Additional density branching off from the N156 glycan (green) can be seen,
indicating the path of the higher-branch glycan residues (dotted line). Residues
from both the HC (orange) and LC (yellow) of PGT128 may be contributing to
interaction with atoms in this density.
(D) R327 in the GDIR motif (red) may make electrostatic interactions with
D100d in CDRH3, as opposed to the backbone interactions indicated in the
X-ray structure. The two interacting residues are shown as yellow sticks.
(E) The density indicates an interaction between Y52e of CDRH2 and the hy-
drocarbon portion of R444 side chain in C5. An interaction between R444 and
the base of N295 glycan (green) may also exist.imaging artifacts such as beam-induced movement (Brilot et al.,
2012; Campbell et al., 2012) and the loss of side-chain resolution
due to high-electron doses (Bartesaghi et al., 2014). Finally, we
show that protein engineering, particularly deglycosylation,
may result in structural information that does not fully recapitu-
late native interactions, as we have proposed here with possible
complex glycan-dependent interactions at N156, and the role ofStructure 23, 1943–N301 for V3 stability. Studies of HIV-1 antibody lineages have
shown that bnAbs undergo a dynamic shift in interaction, with
glycans proximal to the epitope during maturation. For example,
N137 acts as an inhibitory glycan for early precursors of the
PGT121 family of antibodies, whereas the mature antibody can
utilize this glycan in the absence of N332 for neutralization
(Garces et al., 2014). Similarly, the germline antibody of VRC01
does not bind gp120 that is glycosylated at N276 (Jardine
et al., 2013; McGuire et al., 2013). Thus, to guide the maturation
of HIV bnAbs that require high levels of somatic mutation it is
crucial that we recognize all of the epitope contacts so we can
develop the proper vaccine prime and boost immunogens that
mimic the native Env trimer. Cryo-EM is now situated to make
significant contributions in this area, complementing X-ray crys-
tallographic studies that are often limited due to the nature of the
technique.
EXPERIMENTAL PROCEDURES
Complex Formation and Sample Preparation
The purified BG505 SOSIP.664 trimers were mixed with PGT128 Fab using a
10-fold molar excess of the Fab. The mixture was incubated for 1 hr at room
temperature. This trimer-Fab complex was purified by size-exclusion chroma-
tography using a Superose 6 column (GE Healthcare) in 50 mM Tris (pH 7.4)
and 150 mM NaCl. The fractions containing the complex were pooled
and concentrated using a 100-kDa concentrator (Amicon Ultra, Millipore)
to 2.5 mg/ml. 5 ml of the complex was incubated with 3 ml of fresh n-do-
decyl-b-D-maltoside solution at 1.8 mM, to prevent aggregation of the
complex. At 4C, 3 ml of this mixture was applied to a CF-2/2-4C C-Flat grid
(Electron Microscopy Sciences, Protochips) which had been plasma cleaned
for 5 s using amixture of Ar andO2 (Gatan Solarus 950 Plasma system), blotted
off, and then immediately plunged into liquid ethane using a manual freeze
plunger.
Data Collection
Micrographs were collected on an FEI Titan Krios operating at 300 KeV
coupled with a Gatan K2 Summit direct electron detector via the Leginon inter-
face (Suloway et al., 2005). Each exposure image was collected at 22,5003,
resulting in a pixel size of 1.31 A˚/pixel in the counting mode, using a dose
rate of 10 e/pixel/s, and 200 ms exposure per frame. The data were
collected in two separate data-collection sessions, resulting in a total of
2,111 micrographs collected in 85 hr. The total dose received for the first
data collection accounting for 64% of the total collected micrographs was
32.88 e/A˚2, and for the second data collection 35.07 e/A˚2. The nominal de-
focus range used for both datasets was 1.50 to 3.50 mm (Table S1).
Data Processing
All of the collected frameswere aligned prior to processing (Li et al., 2013). CTF
estimation was carried out using CTFFind3 (Mindell and Grigorieff, 2003), and
particles were picked using an automated particle-picking program imple-
mented in the Appion software package (Voss et al., 2009). Particles were
stacked using a box size of 2563 256 pixels at 1.31 A˚/pixel in EMAN boxer.py
via Appion (Lander et al., 2009). Two rounds of reference-free 2D classification
were carried out using multi-variate statistical analysis/multi-reference anal-
ysis (Ogura et al., 2003) using a binning factor of 4, to remove amorphous
particles that were clearly not the protein complex of interest. Particles in
ambiguous classes were left in for sorting by 3D classification. To speed up
data processing the two datasets were initially processed independently, us-
ing the same methods. After 2D sorting, the 43 binned particles were sub-
jected to 3D classification using RELION 1.3 (Scheres, 2012a, 2012b), starting
with an initial referencemodel of an unliganded trimer filtered to 60 A˚ resolution
without imposing symmetry, and requesting four classes. Particles belonging
to three-fold symmetric, PGT128-bound models were then extracted, and
were put through a second round of 3D classification. Classes with the best
trimer density were selected for final, unbinned refinement. Refinements1951, October 6, 2015 ª2015 Elsevier Ltd All rights reserved 1949
were carried out in RELION 1.3 with C3 symmetry imposed, independently for
the two datasets and also with the two datasets combined (Table S1) (Scheres,
2012a, 2012b; Scheres and Chen, 2012). Post-refinement, a shape-fitting
mask excluding the Fab constant domain was generated. The final iteration
of the previous refinement was then allowed to refine until convergence (three
additional iterations) with this mask applied. The final resolution was 4.36 A˚ at
an FSC cutoff of 0.143. The FSC was calculated using a soft-edged mask with
a Gaussian falloff, encompassing the entire structure, including the Fab con-
stant regions, for all models.
Model Building and Refinement
The initial atomic model was generated by fitting the gp140 portion of the
BG505 SOSIP.664 X-ray structure (4TVP) (Pancera et al., 2014) and the
Fab variable region of gp120 eOD bound PGT128 Fab structure (3TYG) (Pej-
chal et al., 2011) into the 4.36-A˚ resolution EM structure. This model is the
equivalent of a template model for phasing in X-ray crystal structure determi-
nation by molecular replacement. For this step, all glycans were temporarily
removed, since RosettaRelax does not handle glycans. Building and refine-
ment were carried out iteratively in Coot (Emsley and Cowtan, 2004) and
RosettaRelax, a computational modeling program that uses cryo-EM density
as a constraint when refining a low-resolution model by energy relaxation
(DiMaio et al., 2009, 2015). After completion of the protein refinement, the
glycans were modeled back into the structure. Large glycans were grafted
from previously published PDB structures, then edited (N301 and N332,
PDB: 3TYG [Pejchal et al., 2011]; N262, PDB: 4RQS [Kong et al., 2015]).
All glycan torsions were manually adjusted and checked via pdb-care (Lut-
teke and von der Lieth, 2004). Few residues in the protein that Rosetta failed
to place into the side-chain densities were modified manually via rotamer
flips in Coot. Model analysis and figure making were carried out in Coot,
PyMOL, and UCSF Chimera.
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The EM reconstructions of BG505 SOSIP.664-PGT128 Fab complex at 4.47
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atomic model has been deposited in the PDB under accession code PDB:
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